Tesi sul tema "Ventricular function"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 saggi (tesi di laurea o di dottorato) per l'attività di ricerca sul tema "Ventricular function".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi le tesi di molte aree scientifiche e compila una bibliografia corretta.
McCormick, Matthew. "Ventricular function under LVAD support". Thesis, University of Oxford, 2012. http://ora.ox.ac.uk/objects/uuid:0d49ba30-b508-4c69-9ba6-b398d4338c01.
Testo completoClark, Simon John. "Right ventricular function in respiratory distress syndrome". Thesis, University of Liverpool, 2001. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250478.
Testo completoHedman, Anders. "Noninvasive evaluation of the effects of coronary artery bypass grafting on myocardial function /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-761-8/.
Testo completoDanton, Mark Henry Dunn. "Studies in right ventricular function : employing the conductance catheter method for ventricular volume determination". Thesis, Queen's University Belfast, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326470.
Testo completoSmall, Alexander. "Assessing ventricular function in patients with atrial fibrillation". Thesis, University of Glasgow, 2012. http://theses.gla.ac.uk/3564/.
Testo completoMacnee, W. "Right ventricular function in chronic bronchitis and emphysema". Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383973.
Testo completoMaret, Eva. "Noninvasive Evaluation of Myocardial Ischemia and Left Ventricular Function". Doctoral thesis, Linköpings universitet, Klinisk fysiologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-18315.
Testo completoMüller-Brunotte, Richard. "Diastolic heart function in hypertension-induced left ventricular hypertrophy /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-898-3/.
Testo completoFlannery, Daniel John. "Noninvasive assessment of ventricular function after acute myocardial infarction". Thesis, Queen's University Belfast, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.335937.
Testo completoClarkson, Peter Bruce Mark. "Studies of left ventricular diastolic function inhealth and disease". Thesis, University of Dundee, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337397.
Testo completoChang, Jessica T. (Jessica Tzung-Min). "The formation and function of the brain ventricular system". Thesis, Massachusetts Institute of Technology, 2012. http://hdl.handle.net/1721.1/72618.
Testo completoThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Cataloged from student submitted PDF version of thesis.
Includes bibliographical references.
The brain ventricular system is composed of a highly conserved set of cavities that contain cerebrospinal fluid (CSF), a protein-rich fluid essential for brain function. However, little is known about the function of embryonic CSF (eCSF), or the mechanisms of CSF production, retention, and circulation that regulate brain ventricle shape and size. Here we present data that begins to dissect the mechanisms governing CSF dynamics during zebrafish embryonic development. Our data indicate that the Na,K-ATPase regulates three aspects of brain ventricle development essential for normal function - neuroepithelial formation, permeability, and CSF production. Formation of a cohesive neuroepithelium requires both the alpha subunit (Atp1a1) and the regulatory subunit, Fyxd1, while only Atp1a1 modulates neuroepithelial permeability. Further, RhoA regulates both neuroepithelium formation and permeability, downstream of the Na,KATPase. Finally, we identified a RhoA-independent process, likely CSF production, which requires Atp1a1, but not Fxyd1. Therefore, formation of the vertebrate brain ventricles requires both production and retention of CSF. Although the embryonic brain ventricles contain large quantities of eCSF little is known about the function of the fluid or the mechanisms that drive fluid production. We developed a method to manually drain eCSF from zebrafish brain ventricles and show that eCSF is necessary for cell survival within the neuroepithelium. Further, increased retinol binding protein 4 (Rbp4), retinoic acid synthesis, and retinoic acid signaling via the PPAR? (peroxisome proliferatoractivated receptor gamma) receptors, prevents neuroepithelial cell death. Thus, we present a novel role for Rbp4 and retinoic acid synthesis and signaling during embryonic brain development. Finally, we also developed an assay to visualize CSF flow in the embryonic zebrafish. We found that the midbrain-hindbrain boundary acts as a barrier preventing CSF movement between the midbrain and hindbrain, while CSF moves freely between the midbrain and forebrain. Additionally, the heartbeat contributes to CSF movement increasing mixing between the hindbrain and forebrain/midbrain compartments. Furthermore, we determined that hydrocephalic phenotypes observed in zebrafish are due to abnormalities in CSF production, retention and flow. These data demonstrate the importance of CSF dynamics during development and further suggest that disruption of these processes can all result in hydrocephalus.
by Jessica T. Chang.
Ph.D.
Long, Karen Jane. "Echocardiographic studies of valvular and ventricular function in horses". Thesis, University of Edinburgh, 1993. http://hdl.handle.net/1842/30398.
Testo completoPATTONERI, PAOLO. "Left ventricular myocardial performance". Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2010. http://hdl.handle.net/2108/1163.
Testo completoRecently, a conceptually new Doppler index that combines the assessment of systolic and diastolic left ventricular (LV) performance was proposed by Tei and co-workers. This Myocardial Performance Index (MPI), which is defined as the sum of isovolumetric contraction time and isovolumetric relaxation time divided by the ejection time, was reported to be simple, non-geometrical, non-invasive, reproducible and independent of the heart rate and blood pressure. The MPI has been shown to have significant clinical utility. It is prolonged in many cardiac diseases even in the absence of clinical signs. Studies have demonstrated that MPI correlates well with invasive measures of both systolic and diastolic function in adults and provides prognostic information about morbidity and mortality in patients with ischemic heart disease, cardiac amyloidosis, dilated cardiomyopathy, primary pulmonary hypertension and detects early LV functional improvement as a result of drug therapy. MPI is also abnormal in individuals without overt cardiac disease who have risk factors such as diabetes mellitus and treated and untreated hypertension. Orem et al. demonstrated progressively more abnormal MPI with increasing degrees of albuminuria in a diabetic population. More recently, the MPI has shown promise in the assessment of right ventricular function in fetus, children and adults with various heart disease. The aim of this thesis was to analyse the LV myocardial performance, applying the MPI in various physiological and pathological conditions to elucidate some aspects of LV myocardial dynamic. In the first study, we demonstrated that LV geometry represents an important determinant of the myocardial performance. In fact, our data demonstrates a correlation between MPI and RWT but not with LVM/BSA. The MPI geometry-dependence must be taken into consideration during the application of the Index for the evaluation of myocardial performance, and when used as a prognostic marker in cardiac disease where the LV geometry could be modified. In the second study the MPI has been confirmed able to identify the earliest abnormalities of cardiac performance at echocardiography in a homogeneous group of uncomplicated asymptomatic type 2 diabetic patients with very short duration of disease with or without hypertension. The MPI increase was mainly due to a prolongation of IRT. A correlation between MPI and the HbA1c value, was found indicating its role as an early marker of metabolic control. Our findings may have important clinical implications. First, this index could provide an easy approach to detect an earliest phase of diabetic cardiomyopathy that precede diastolic dysfunction, and to monitor the natural history of the diabetic disease. Second, MPI could be useful for indirectly assess the metabolic control or suggest an early start of specific pharmacological treatments that may help the clinical course of diabetic cardiomyopathy. Most importantly, whether such abnormalities may be reverted by optimal metabolic control and/or pharmacologic treatments could be determined. Diagnosing pre-clinical diabetic cardiomyopathy early through MPI is not only important but also may turn out to be essential for the appropriate clinical testing of new therapeutic approaches to diabetic disease. Finally, the MPI appears to be a sensitive noninvasive technique for detecting significant subclinical left ventricular dysfunction, in patients with multiple sclerosis treated with low dose of mitoxantrone, an antracenedione antineoplastic agent. Besides, provides important prognostic information for the risk of future cardiotoxicity, beyond other conventional echocardiographic measurements. We expect that MPI may be an adjunctive parameter to the conventional echocardiography in monitoring cardiac side effects and for detecting sub-clinical cardiotoxicity of mitoxantrone. In conclusion, a simple measure of Doppler index, combining systolic and diastolic time interval as an expression of global myocardial performance, correlates with overall cardiac function, seem to be a useful predictor of clinical outcome and could be an adjunctive index for the diagnosis and for the clinical management of patients with many cardiac and systemic disease.
Mendes, Paulo Roberto Araújo 1968. "Função pulmonar e remodelamento ventricular esquerdo em indivíduos hipertensos = Lung function and left ventricular remodeling in hypertensive subjects". [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312297.
Testo completoDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-25T05:29:30Z (GMT). No. of bitstreams: 1 Mendes_PauloRobertoAraujo_M.pdf: 976609 bytes, checksum: d5b069ade658cb23f9494d04dbbb255d (MD5) Previous issue date: 2014
Resumo: Pacientes hipertensos estão predispostos ao remodelamento do ventrículo esquerdo (VE) e frequentemente apresentam queda na função pulmonar quando comparados à população geral. Neste estudo investigamos a associação entre dados espirométricos e ecocardiográficos em indivíduos hipertensos não fumantes. Num estudo transversal, 107 pacientes hipertensos (60 mulheres) foram avaliados por análises clínicas, hemodinâmicas, laboratoriais e ecocardiográficos. A capacidade vital (CV), a capacidade vital forçada (CVF), o volume expiratório forçado no primeiro segundo (VEF1), o volume expiratório forçado no sexto segundo (VEF6) e a relação VEF1\CVF foram medidos através de espirometria. Nas mulheres, o índice de massa do VE e a relação E\Em correlacionaram-se com variáveis espirométricas, enquanto que a espessura relativa da parede somente se correlacionou com o percentual de CVF previsto. Nos homens, somente o índice de massa do VE se correlacionou com variáveis espirométricas. Análise de regressão tipo stepwise mostrou que o índice de massa do VE não esteve associado com nemhum parâmetro espirométrico após ajuste para os potenciais confundidores nos homens, enquanto que CVF e VEF6 se associaram de maneira significativa com a massa do VE e a relação E\Em no sexo feminino. Entretanto, marcadores inflamatórios tais como Proteína C reativa plasmática e os níveis séricos de metaloproteinases 2 e 9 não influenciaram estas associações. Em conclusão, o declínio na função pulmonar está independentemente associado com maior massa e pior função diastólica do VE em mulheres hipertensas
Abstract: Hypertensive patients are predisposed to left ventricular (LV) remodeling and frequently exhibit decline in lung function as compared to the general population. Here, we investigated the association between spirometric and echocardiographic data in non-smoking hypertensive subjects. In a cross-sectional study, 107 hypertensive patients (60 women) were evaluated by clinical, hemodynamic, laboratory and echocardiographic analysis. Vital capacity, forced vital capacity (FVC), forced expired volume in 1s (FEV1) and in 6s (FEV6) and FEV1/FVC ratio were estimated by spirometry. In women, LV mass index and E/Em ratio correlated with spirometric variables, while relative wall thickness only correlated with the percentage of predicted FVC. In men, only LV mass index correlated with spirometric variables. Stepwise regression analysis showed that LV mass index did not associate with any spirometric parameter after adjustment for potential confounders in men, while markers of restrictive and obstructive lung dysfunction, such as reduced FVC and FEV6, were significantly associated with LV mass and E/Em ratio in women. Furthermore, inflammatory markers such plasma C-reactive protein and matrix-metalloproteinases-2 and -9 levels did not influence these associations. In conclusion, decline in lung function is independently associated with higher LV mass and worse LV diastolic function in hypertensive women
Mestrado
Clinica Medica
Mestre em Clinica Medica
Zhao, Ying. "Effect of valve replacement for aortic stenosis on ventricular function". Doctoral thesis, Umeå universitet, Institutionen för folkhälsa och klinisk medicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-46809.
Testo completoLeung, Dominic Y. C. South Western Sydney Clinical School UNSW. "Exercise and left ventricular function in chronic mitral valve insufficiency". Awarded by:University of New South Wales. South Western Sydney Clinical School, 2002. http://handle.unsw.edu.au/1959.4/18808.
Testo completoJacob, Gary. "Quantifying regional left ventricular function using spatio-temporal tracking techniques". Thesis, University of Oxford, 1999. http://ora.ox.ac.uk/objects/uuid:051f5820-e6fb-4757-8669-b464fb050db9.
Testo completoLevin, Andrew Ian. "A study of right ventricular function during one lung anesthesia". Thesis, Stellenbosch : University of Stellenbosch, 2004. http://hdl.handle.net/10019.1/16060.
Testo completoENGLISH ABSTRACT: Background to the study OLA can give rise to certain problems: 1. A significant decrease in lung volume is reported to occur in the dependent lung during OLA in the LDP. This decrease in lung volume can result in an acute increase in opposition to RV ejection. The potential problem is that the right ventricle is a thin walled structure that can generate considerably less work than the thicker walled LV. It possesses little reserve to deal with an acute rise in afterload as may occur during acute lung injury or after lung resection. Therefore, this increase in afterload during OLA may potentially impair RV-PA coupling. Albeit this potential problem exists, the changes in RV afterload and how the right ventricle performs during OLA have not been well studied. 2. Arterial hypoxemia, due mainly to venous blood being shunted via the non-ventilated lung, may present a clinical problem during one lung ventilation. a. The relative resistances of the pulmonary vascular beds of the dependent ventilated and nondependent non-ventilated lungs are an important factor governing shunting and thus arterial oxygenation during one lung anesthesia. A high non-ventilated lung PVR and low ventilated lung PVR will facilitate good arterial oxygenation during OLA. An increase in non-ventilated lung PVR is governed predominantly by hypoxic pulmonary vasoconstriction. A low opposition to pulmonary blood flow in the dependent lung is facilitated predominantly by a high alveolar oxygen tension and normal lung volume, albeit other factors also play a role in this regard. b. The saturation and oxygen content of mixed venous blood will contribute significantly to the arterial oxygenation in the presence of a large shunt as occurs during OLA. i. On the one hand, venous desaturation as a cause of hypoxemia during one lung anesthesia has not as yet been systematically addressed in the literature. ii. On the other hand, if RV afterload increases to such a degree that it leads poor RV performance, this may cause impairment of global circulatory efficiency and lead to mixed venous desaturation. The question that has been raised is whether inotrope infusions could improve RV and LV performance, cardiac output, and thereby the efficiency of the circulation. Increases in the efficiency of the circulation will result in an improvement in mixed venous and arterial oxygenation in the presence of a large shunt. Nonetheless, the administration of inotrope infusions in the presence of a shunt and during OLA has been reported to aggravate hypoxemia. Thus at the time of conducting the study, conflicting reports of whether increasing cardiac output and thereby mixed venous oxygenation would increase or decrease arterial oxygenation during OLA In the light of the above, the researcher thus investigated RV afterload, RV performance and coupling to its load during OLA. The study also addressed the question whether different levels of inotrope infusion or PEEP hadbeneficial or deleterious effects on RV afterload, RV performance and coupling to its load during OLA. Furthermore, if cardiac output increased during OLA secondary to the infusion of inotropes, would this improve the efficiency of the circulation, mixed venous oxygenation and thus the arterial oxygenation during OLA, or would it worsen shunt and arterial oxygenation during OLA? Control group: OLA and the opposition to pulmonary flow Pulmonary arterial elastance increased by between 18 to 36% during OLA and mean PAP rose by 32% after initiation of OLA This increase in mean PAP on initiation of OLA is greater than that observed by certain investigators but similar to that seen previously in patients with damaged lungs. The question arose as to why pulmonary artery pressure rises during OLA? From consideration of Ohm’s law, pressure may be regarded as the product of flow and resistance (Mark, Slaughter et al. 2000). The increase in mean PAP during OLA is due to two reasons. 1. Firstly, the pressure versus flow curve is likely to be steeper during OLA. This is because pulmonary vascular recruitment and dilatation (pulmonary vascular reserve) is more limited in scope in these patients than is usual and most likely accounts for the increase in pulmonary artery pressure during OLA. The reasons for the limited pulmonary vascular reserve in the DL during OLA include: a. The pulmonary vascular bed of patients subjected to OLA is frequently abnormal because of its underlying pathology, b. During OLA in the lateral decubitus position, lung volume decreases to a greater degree than during two-lung anesthesia (Klingstedt, Hedenstierna et al. 1990). c. This decrease in lung volume will be further aggravated by DLT malpositions, secretions and blood, and absorption atelectasis due to the use of high concentrations of oxygen (Hedenstierna 1998; Krucylak, Naunheim et al. 1996). d. Excessive amounts of extrinsic or intrinsic PEEP during OLA can compress the intra-alveolar capillaries and deleteriously affect the pulmonary vascular resistance (Ducros, Moutafis et al. 1999; Inomata, Nishikawa et al. 1997; Bardoczky, Yernault et al. 1996; Yokota, Toriumi et al. 1996). 2. Secondly, there is greater flow through this vascular bed that possesses a higher resistance. It is noteworthy that the increase in mean PAP did not exceed a value of 25 mm Hg during OLA, even though cardiac output increased by 30%. However, in studies conducted in patients with “damaged lungs”, greater increases in PA pressure (accompanied by a decrease in RVEF) have been reported to occur on PA ligation. A question arises as to why differences exist between PA clamping and OLA? The answer may well be that the observed plateau in the rise of PA pressure during OLA is as a result of progressive diversion of flow to the NDL as PA pressure rises. Support for such a suggestion comes from the observation that concomitant with increases in PA pressure during OLA, HPV is progressively inhibited and shunt fraction progressively rises. This increase in shunt fraction that has been observed to occur as PA pressure rises, reflects an increase in diversion of pulmonary blood flow to the NDL. The impact of diversion of this blood to the NDL is that it possibly acts as a safety mechanism limiting increases in PA pressure and other indices of opposition to pulmonary flow during OLA. This “blow-off effect” will protect the RV until PA clamping occurs.Control group: OLA and RV function The current study represented the opportunity to investigate the significance of the abovementioned increases in PA pressures and elastance on RV performance during OLA. The current study indicates that at the moderate (30%) increases in PAP that accompanied the initiation of OLA, RV performance, as judged by stroke volume, cardiac index, RVEF and RVSWI, did not deteriorate compared to the baseline awake status. In fact, cardiac output increased following surgical incision: this was probably due to sympathetic nervous system stimulation. This observation also fits in with other studies in which RV performance usually only begins to deteriorate when indices of opposition to RV ejection reach 200 to 250% of baseline. Furthermore, a constant preload, as indicated by unchanged central venous and pulmonary artery wedge pressures, and right ventricular end-diastolic volumes were observed throughout the study period. In other words, this increase in RV afyterlad did not cuse the RV to dilate durign OLA. The relationship between stroke work and afterload will vary, depending on the contractile reserve of the ventricle. In this regard, it could be concluded that under the conditions operative in the current study, the RV was operating on the upslope of the RVSWI versus Ea relationship. This supports the observation that RV function is well preserved during OLA. In conclusion, regarding the indices of opposition to pulmonary flow and RV performance during OLA, it can be concluded that: 1. Opposition to RV ejection increases. This is evidenced by a 30% rise in mean PAP and 18 to 36% increase in pulmonary arterial elastance. 2. Right ventricular performance as indicated by RVSWI, RVEF and stroke volume does not decrease during OLA compared with when the patients awake or subjected to two-lung anesthesia. 3. Furthermore, coupling between the RV and its load is well preserved during OLA. This would imply that the RV operates at close to maximal efficiency during OLA and that RV stroke work reserve is present during OLA. It is likely that the RV, which continues operating as a flow pump as it does in normal life, easily copes with the small increases in RV afterload during OLA. Dobutamine during OLA: opposition to pulmonary flow and RV performance The effects of dobutamine infusions on RV performance during OLA can be summarised as follows: 1. Low rates of dobutamine infusion (3 ug.kg-1.min-1) increased cardiac output, stroke volume, and RVSWI. The administration of dobutamine 3 ug.kg-1.min-1 was not accompanied by increases in RV afterload. Therefore, low infusion rates of dobutamine did benefit RV-PA coupling during OLA. 2. However, administration of higher dosages of dobutamine (5 and 7 ug.kg-1.min-1) during OLA was associated with increases in certain indices of opposition to pulmonary blood flow. For example, PA elastance, mean PA pressure, and PVR increased by 30% to 40% compared to both when the patients were awake and when both lungs were being ventilated. Furthermore, PA compliance decreased by up to 61% when dobutamine 5 and 7 ug.kg-1.min-1 were infused compared to the OLA step when dobutaminewas not administered. The increases in mean PAP and PVR are considered to be of limited clinical significance. However, the decrease in PA compliance during the infusion of the highest dosage of dobutamine is clinically significant. PA compliance represents one of the factors determining vascular impedance in the Windkessel model of the circulation. The increases in opposition to pulmonary flow and lack of progressive increase in indices of RV performance are in contrast to what is expected to occur on administration of increasing dosages of the inotrope and pulmonary vasodilator, dobutamine. The reasons for the increase in opposition to pulmonary flow include exhaustion of the pulmonary vascular reserve during OLA at the high cardiac indices of 5 to 5.5 l.min-1.m-2. This aspect overshadowed the expected pulmonary vasodilator effects of dobutamine. Moreover, it is probable that the increase in RV afterload was significant enough to prevent right ventricular performance increasing as would be expected with the administration of progressively higher dosages of inotrope. While dobutamine was being administered during OLA, mean PAP increased to a maximum of 24.9 ± 6.2 mm Hg at a cardiac index of 5.5 ± 1.2 l.min-1.m-2. However during OLA, in the control group, mean PAP was 24.0 ± 7.7 mm Hg at the maximum cardiac index of 4.4 ± 1.1 l.min-1.m-2. This represented a relatively limited rise in PA pressure compared with administration of dobutamine alone. The most likely reason why there may have been a limited increase in mean PAP while dobutamine was being administered is that the “blow off” effect of the NDL vasculature limited the rise in PA pressure. Oxygenation during OLA With regard to oxygen flux, venous and arterial oxygenation during OLA in the control group, the following was observed: 1. Induction of anesthesia and the approximately 1O Celsius decrease in temperature induced an approximately 40% decrease in VO2 that continued during OLA. 2. Initiation of OLA resulted in an increase in cardiac output compared to baseline OLA and awake states. 3. The consequence was an increase in S��������O2 from 75% and P��������O2 from 5.4 kPa when the patients were awake to a P��������O2 of 9.0 ± 1.7 kPa and S��������O2 of 90.6 ± 4.7% during one-lung anesthesia. 4. During OLA, the significant increase in venous oxygenation resulted in an increase in arterial oxygenation compared to the awake state in spite of the approximately 37% shunt occuring during OLA. 5. Under conditions in the present study, dobutamine administration during OLA did not improve, but maintained the already high venous and arterial oxygenation compared with OLA alone. Therefore, the study hypothesis, that dobutamine would induce improvement in RVF and the increase in cardiac output during OLA would improve arterial oxygenation, does not hold in the current study. The hypothesis that dobutamine administration and improving cardiac output during OLA would increase arterial oxygenation was therefore rejected. However, the rejection of the hypothesis means that the findings of the current study are in contrast to the findings of Mathru et al, and Nomoto and Kawamura. These authors demonstrated that inotrope administration resulted in an increase in arterial oxygenation. Nonetheless, the different results are not at odds with each other. In fact, these differences help to clarify the effect of increases in cardiac output on arterial oxygenation in the presence of asignificant shunt. The differences between the studies can be explained in the following way. Conditions in the current study resulted in a favourable DO2/VO2 ratio and a high starting P��������O2 even before dobutamine administration was commenced. Therefore the venous saturations were on the flat part of the oxygen dissociation curve and also on the flat part of the relationship between cardiac output and arterial oxygen content originally described by Kelman, Nunn and colleagues. Further increases in cardiac output and the DO2/VO2 ratio would not be expected to, and did not, increase P��������O2, S��������O2, or C��������O2. Thus, arterial oxygenation content and saturation did not change subsequent to the increase in cardiac output associated with the administration of dobutamine in the current study. In contrast, in the Mathru study, the low starting venous saturations and tensions were improved by increases in the DO2/VO2 ratio. As the starting venous saturation was “low,” significant benefit in arterial oxygenation was obtained on increasing cardiac output in that study. One significant concern for the clinician regarding the administration of the inotrope dobutamine during OLA is that it may increase shunt fraction (Qs/Qt) and thereby decrease arterial oxygenation during one lung ventilation. The influence of dobutamine on arterial oxygenation during OLA may theoretically be related to the balance of the following divergent effects: 1. By improving the relationship between oxygen delivery and consumption, dobutamine increases P��������O2. This increase will benefit arterial oxygenation in the presence of a large shunt, 2. The above has to be weighed against possible increases in VO2 induced by dobutamine, the consequence of which will be a decrease in P��������O2. Such increases in VO2 were not seen on administration of dobutamine in the current study, 3. An increase in PA pressure accompanying the increased cardiac output will oppose HPV and increase shunt in both the dependent and non-dependent lungs, 4. Direct inhibition of HPV by dobutamine and, 5. The influence of P��������O2 on HPV (i.e. high levels of venous oxygenation will inhibit whereas low levels will potentiate HPV). Nonetheless, in spite of the concerns (risk) of hypoxemia on administering dobutamine during OLA, dobutamine administration did not decrease PaO2 or arterial oxygen saturation, and neither did it increase the cost of oxygenation compared to when OLA was conducted in the absence of dobutamine infusions. In addition, the findings of studies conducted by Mathru and colleagues, Nomoto and Kawamura and the current study indicate that under usual clinical conditions present during OLA in the LDP, the administration of low dosages of dobutamine do not increase shunt fraction. In fact, the beneficial effect of the increase in cardiac output on venous oxygenation resulted in an increase in arterial oxygenation in the study by Mathru and colleagues; similar mechanisms were most likely operative in the study conducted by Nomoto and Kawamura. Therefore, there is currently no evidence that the administration of dobutamine in dosages of up to 7 ug.kg-1.min-1 increases shunt and worsens arterial oxygenation in humans subjected to OLA in the LDP. It is apparent that the vasodilatory effects of dobutamine resulting in a possible increase in shunt fraction (Qs/Qt) is therefore not the only factor to consider when studying its effects on arterial oxygenation. What is also of great relevance whenconsidering the effects of an inotrope on arterial oxygenation is the effect of inotropic drugs on the venous oxygen content. It is possible that Qs/Qt could be increased by the administration of inotrope. Nonetheless, if venous oxygenation is favourably affected by the administration of dobutamine, then a depressant effect on arterial oxygenation by an increase in the amount of blood passing via the shunt may be negated. If the increase in venous oxygenation is very significant, there may even be benefits in terms of arterial oxygenation, as was the case in the current study. This approach to how the quality of the blood passing via the shunt affects arterial oxygenation shifts the emphasis on prevention and treatment of hypoxemia during OLA from the lung to the efficacy of the circulation. In other words, the emphasis is shifted from what predominantly happens to the non-ventilated lung (HPV) to primarily the efficacy of oxygen flux during OLA. Extrinsic and intrinsic PEEP and OLA The effects of PEEP on hemodynamics and oxygenation observed during OLA in the current study may be summarised as follows. When PEEP5 was applied to the DL during OLA in the current study: 1. Neither right ventricular function, hemodynamics, oxygen flux nor arterial oxygenation was affected by the application of PEEP5 compared to the step when no external PEEP was applied. 2. Significant amounts of intrinsic PEEP were present during OLA in the control group patients. The degree of intrinsic PEEP was weakly related to the degree of obstructive airways disease present on preoperative LFT’s. 3. The most likely reason why PEEP5 did not make a difference to oxygenation or hemodynamics was the existence of similar amounts of intrinsic PEEP during OLA. These findings confirm Myles’s contention that low levels of intrinsic PEEP may have salutary effects on oxygenation during OLA. When PEEP10 was applied to the DL during OLA in the current study, it led to a decrease in stroke volume. This decrease is predominantly due to a decrease in preload, as PVR does not increase to levels that are known to impair RV performance. The decrease in the DO2/VO2 ratio that was induced by PEEP10 predictably decreases P��������O2 and can potentially lead to impairment of arterial oxygenation. It can therefore be concluded that greater (excessive) amounts of PEEP under more unfavourable circulatory conditions than were observed in the current study, may have deleterious cardio-respiratory effects. In summary, optimising DL volume plays an important role in determining arterial oxygenation. However, the therapeutic index for PEEP is narrow and the anesthesiologist needs to know firstly when the lung volume of the DL approaches FRC and secondly, how to avoid dynamic hyperinflation of that lung. One significant problem is that the best method of monitoring FRC during OLA is not clear at present.
AFRIKAANSE OPSOMMING: Agtergrond tot die studie Eenlongnarkose mag tot sekere probleme aanleiding gee. ’n Betekenisvolle afname in volume van die onderlong vind in die laterale decubitus posisie tydens eenlongnarkose plaas. Hierdie afname in longvolume mag egter ’n akute verhoging in regter ventrikulêre nalading tot stand bring. Die probleem is egter dat die regter ventrikel ’n dunwandige struktuur is wat potensieel baie minder werk as die dikwandige linker ventrikel kan genereer. Die regter ventrikel het min reserwe om ’n akute verhoging in nalading te weerstaan soos wat gebeur met akute longbesering of na longreseksie. Dus die verhoging in nalading wat gepaard gaan met eenlongnarkose mag die koppeling tussen die regter ventrikel en die pulmonale arterie belemmer. Alhoewel hierdie potensiële probleem bestaan, is die verandering albei in regter ventrikulêre nalading en hoe die regter ventrikel funksioneer tydens eenlongnarkose nog nie goed bestudeer nie. 1. Arteriële hipoksemie, hoofsaaklik te wyte aan die groot aftakking via die long wat nie geventileer word nie, mag kliniese probleme tydens eenlongnarkose teweegbring. 2. Die weerstand wat die pulmonale vaskulêre beddens van die geventileerde en nie-geventileerde longe bied teen bloedvloei is belangrike faktore wat aftakking en dus arteriële oksigenasie tydens eenlongnarkose beheer. ’n Hoë weerstand van die nie-geventileerde long en ’n lae weerstand van die geventileerde long se pulmonale vaskulêre beddens sal bevredigende arteriële oksigenasie tydens eenlongnarkose fasiliteer. ’n Verhoging in die pulmonale vaskulêre weerstand van die nie-geventileerde long is hoofsaaklik te wyte aan hipoksiese pulmonale vasokonstriksie. ’n Lae pulmonale vaskulêre weerstand in die geventileerde onderlong is hoofsaaklik gefasiliteer deur ’n hoë alveolêre suurstofspanning en ’n normale long volume, alhoewel alle faktore ook ’n rol in hierdie verband speel. 3. In die teenwoordigheid van die groot aftakking wat bestaan tydens eenlongnarkose, sal die saturasie en suurstof inhoud van gemeng veneuse bloed ’n betekenisvolle bydrae aan arteriële oksigenasie maak. a. Veneuse saturasie as ’n oorsaak van hipoksemie tydens eenlongnarkose, is nog nie sistematies in die literatuur ondersoek nie. b. Indien regter ventrikulêre nalading tot so ’n mate verhoog dat dit tot swak ventrikulêre uitwerp lei, mag dit ’n oorsaak wees van ontoereikendheid van die globale bloedsomloop en tot gemeng veneuse desaturasie lei. Die vraag is dus of verhoging van die kardiale omset deur inotrope ondersteuning die toereikendheid van die sirkulasie kan verbeter. Verbeterde sirkulasie toereikendheid sal tot ’n verhoging in gemeng veneuse en arteriële oksigenasie lei in die teenwoordigheid van ’n groot aftakking. Nietemin, die toediening van inotrope in die teenwoordigheid van ’n groot aftakking tydens eenlongnarkose gerapporteer om hipoksemie te vererger tydens eenlongnarkose. Dus ten tye van die uitvoer van dié studie, is daar uitdrukking gegee tot teenstrydige opinies in die literatuur oftewel verhoging in kardiale omset arteriële oksigenasie sal verbeter of versleg tydens eenlongnarkose.In die lig van die agtergrond hierbo, het die navorser dus regter ventrikulêre nalading, regter ventrikulêre funksie en koppeling van die regter ventrikel met sy lading tydens eenlongnarkose ondersoek. Die studie het ook die vraag benader of inotroop infusies of PEEP goeie of slegte gevolge sou hê op regter ventrikulêre nalading, regter ventrikulêre funksie en koppeling van die regter ventrikel aan sy lading tydens eenlongnarkose. Sou die kardiale omset en die toereikendheid van die sirkulasie sou verbeter sekondêr tot die toediening van inotrope tydens eenlongnarkose, gemeng veneuse oksigenasie en dus arteriële oksigenasie tydens eenlongnarkose verbeter, of sou dit aftakking en arteriële oksigenasie versleg tydens eenlongnarkose? Kontrole groep Pulmonêre elastansie het tussen 18 en 36% verhoog en gemene pulmonale arterie druk het met 32% tydens eenlongnarkose vermeerder. Die verhoging in gemene pulmonale arterie druk met die aanvang van eenlongnarkose is groter as die waardes gesien deur sekere navorsers maar gelyk met waardes gevind in pasiënte met beskadigde longe. Die vraag ontstaan dan hoekom styg pulmonale arterie druk tydens eenlongnarkose? volgens Ohm se Wet, mag druk as die veelvoud van vloei en weerstand beskou word. Die verhoging in gemene pulmonale arterie druk tydens eenlongnarkose is daarvolgens hoofsaaklik te wyte aan twee redes. 1. Eerstens, die kurwe van druk teenoor vloei is waarskynlik styler tydens eenlongnarkose. Hierdie is omdat pulmonale vaskulêre werwing en verwyding (pulmonale vaskulêre reserwe) is meer beperk as nornaal in pasiënte met longsiekte. Hierdie is die waarskynlikste rede hoekom pulmonale arterie druk tydens eenlongnarkose verhoog. Die redes hoekom die pulmonale vaskulêre reserwe in die onderste long tydens eenlongnarkose beperk is sluit in die volgende: 1.1 Die pulmonale vaskulêre bed van pasiënte onderwerp aan eenlongnarkose mag abnormaal wees weens die onderliggende long patologie, 1.2 Tydens eenlongnarkose in die laterale decubitus posisie, is long volume in hoë mate verminder as tydens tweelongnarkose, 1.3 Die voorafgenoemde vermindering in longvolume sal verder verminder word deur wanposisies van die dubbellumenbuis, sekresies en bloed, en absorpsie atelektase. 1.4 Te hoë vlakke van PEEP, oftewel intrinsiek of ekstrensiek van oorsprong, sal die intraalveolêre vate toedruk en so die pulmonale vaskulêre weerstand verhoog. 2. Tweedens, is daar groter vloei deur hierdie vaskulêre bed wat ‘n hoër weerstand bevat. Dit is opmerkingswaardig dat die verhoging in gemene pulmonale arterie druk ‘n waarde van 25 mmHg nie oorskry het nie tydens eenlongnarkose, alhoewel kardiale omset met 30% verhoog het. In pasiënte met beskadigde longe, het vorige studies egter bewys dat groter verhoging in PA druk gebeur tydens afbinding van die pulmonale arterie. Die vraag ontstaan dus hoekom daar verskille bestaan tussen wat gebeur tydens afbind van die pulmonale arterie en eenlongnarkose? Die antwoord mag wees dat die beperking in die styging in PA druk tydens eenlongnarkose as gevolg van ‘n progressiewe afleiding van bloedvloei na die nie-geventileerde long gebeur sodra pulmonale arterie druk styg tydens eenlongnarkose. Die implikasie van die afleiding van bloed na die nie geventileerde long is dat dit as ‘n veiligheids meganisme optree en verdere styging in pulmonale arterie druk beperk tydens eenlongnarkose. Hierdie afblaas meganisme sal die regter ventrikel beskerm tot en met PA afbind.Kontrole groep: eenlongnarkose en regter ventrikulêre funksie Die huidige studie bied die geleentheid om die betekenis van die voorafgenoemde verhoging in PA drukke en elastansie op regter ventrikulêre funksie tydens eenlongnarkose te ondersoek. Die huidige studie dui aan dat die 30% verhoging in pulmonale arterie druk wat met die aanvang van eenlongnarkose plaasvind, glad nie regter ventrikulêre funksie belemmer nie indien dit vergelyk word met die basislyn wakker staat. In teendeel, kardiale omset het verhoog na chirurgiese insnyding: hierdie verhoging is waarskynlik te wyte aan simpatiese senuwee stimulasie na die chirurgiese insnyding. Hierdie waarnemings pas in ook met ander studies waartydens regter ventrikulêre ejeksie alleenlik begin om af te neem indien die indekse van opposisie tot regter ventrikulêre ejeksie 200 tot 250% van basislyn bereik. Verder, die induksie van voorlading, naamlik sentrale veneuse druk, pulmonale arterie wigdruk en regter ventrikulêre einddiastoliese volumes is onveranderd tydens die huidige studie; dit beteken die ventrikel het nie gedilateer het nie tydens die verhoging in regter ventrikulêre nalading. Die verband tussen slagwerk en nalading sal varieer, afhanklik van die kontraktiele status van die ventrikel. In hierdie opsig, kon ons aflei dat die regter ventrikel, onder omstandighede wat tydens diė studie plaasgevind het, gefunksioneer het op die stygende been van die verband tussen regter ventrikulêre slagwerk en pulmonale arterie elastansie. Hierdie waarneming ondersteun die argument in die vorige paragraaf dat die regter ventrikel funksie behoue is tydens eenlongnarkose. Ter opsomming omtrent die indekse van opposisie tot pulmonale vloei en regter ventrikulêre funksie tydens eenlongnarkose: 1. Opposisie tot regter ventrikulêre uitwerp verhoog. Die bewys hiervoor is ’n 30% verhoging in gemene pulmonale arterie druk en ’n 36% verhoging in pulmonale arterie elastansie. 2. Ten spyte van die verhoging in weerstand teen RV uitwerping, het regter ventrikulêre funksie (soos bepaal deur regter ventrikulêre slagwerk indeks, regter ventrikulêre ejeksie fraksie en slag volume), nie verminder tydens eenlongnarkose in vergelyking met die waardes verkry wanneer die pasiënte wakker is of aan tweelongnarkose onderwerp is. 3. Ons kon ook aflei dat die koppeling tussen die regter ventrikel en sy lading goed behoue is tydens eenlongnarkose. Die implikasie hiervan is dat regter ventrikulêre slagwerk reserwe teenwoordig is tydens eenlongnarkose. Tydens eenlongnarkose funksioneer die regter ventrikel as ’n vloeipomp, net soos in normale lewe; dit beteken dat en die klein verhoging in regter ventrikulêre nalading wat ondervind word tydens eenlongnarkose maklik getolereer word. Dobutamien tydens eenlongnarkose: opposisie tot pulmonale vloei en regter ventrikulêre funksie Die uitwerking van dobutamien op regter ventrikulêre funksie tydens eenlongnarkose kan as volg opgesom word: 1. Lae dosisse dobutamien (3 μg.kg-1.min-1) verhoog kardiale omset, slagvolume en regter ventrikulêre slagwerkindeks. Die toediening van dobutamien 3 μg.kg-1.min-1 het nie saamgegaan met ‘n verhoging in regter ventrikulêre nalading nie. Dus, lae dosisse van dobutamien het wel die koppeling tussen die regter ventrikel en die pulmonale vaskulatuur tydens eenlongnarkose verbeter.2. Nietemin, albei die hoër dosisse van dobutamien (5 en 7 μg.kg-1.min-1) tydens eenlongnarkose het verhogings in die opposisie tot pulmonale bloedvloei teweeggebring. Byvoorbeeld, PA elastansie, gemene PA druk en pulmonale vaskulêre weerstand het met 30 tot 40% verhoog in vergelyking met die waardes gekry toe die pasiënte wakker was en toe albei longe geventileer is. ’n Belangrike opmerking in hierdie opsig is dat pulmonale arterie vervormbaarheid tydens eenlongnarkose met 61% verminder het tydens albei dobutamien 5 en 7 μg.kg-1.min-1. Die verhogings in gemene pulmonale arterie druk en pulmonale vaskulêre weerstand is, volgens mening, nie van kliniese of statistiese betekenis nie, alhoewel die vermindering in PA vervormbaarheid tydens die dobutamien 7 μg.kg-1.min-1 infusie wel van kliniese betekenis is. PA vervormbaarheid weerspieël een van die faktore wat vaskulêre impedansie in die 3- element Windkessel model van sirkulasie het. Die verhoging in opposisie tot pulmonale vloei en die afwesigheid van progressiewe verhogings in indekse van regter ventrikulêre funksie is nie wat verwag word indien die dosisse van die inotroop en pulmonale vasodilator dobutamien, progressief verhoog word. Die redes hoekom die opposisie tot pulmonale vloei verhoog tydens die toediening van dobutamien sluit in die uitwissing van die pulmonale vaskulêre reserwe tydens eenlongnarkose. Tydens die hoë kardiale indekse van 5 tot 5.5 μg.kg-1.min-1. is die pulmonale vaskulêre reserwe uitgeput en die meganisme het die verwagte pulmonale vaskulêre vasodilatasie van dobutamien oorskadu. Bowendien is dit waarskynlik dat die verhoging in regter ventrikulêre nalading betekenisvol genoeg was om te verhoed dat regter ventrikulêre funksie progressief verhoog soos sou verwag word met die administrasie van hoër dosisse inotroop. Die administrasie van dobutamien tydens eenlongnarkose het gemene pulmonale arterie druk verhoog tot ’n maksimum van 24,9 ± 6.2 mm Hg teen ’n kardiale indeks van 5.5 ± 1.2 l.min-1.m2. Nietemin is gemene pulmonale arterie druk 24.0 ± 7.7 mm Hg teen die maksimum kardiale indeks in die kontrole groep van 4.4 ± 1.1 l.min-1.m-2 tydens eenlongnarkose in die kontrole groep. Hierdie weerspieël dus ’n relatief beperkte verhoging in pulmonale arterie druk in vergelyking met die verhoging in pulmonale arterie druk wat gebeur het tydens die administrasie van dobutamien. Die waarskynlikste rede hoekom daar ’n beperkte verhoging in pulmonale arterie druk sou gewees het tydens die infusie van dobutamien is die afblaas effek van die nie-geventileerde long wat die verhoging in PA druk beperk het. Oksigenasie tydens eenlongnarkose Die volgende waarnemings is gemaak in verband met suurstof vloed, veneuse en arteriële oksigenasie tydens eenlongnarkose in die kontrole groep: 1. Die kombinasie van Induksie van narkose en die 1ºC vermindering in temperatuur het saamgegaan met ’n 40% vermindering in suurstof verbruik tydens twee long narkose. Hierdie vermindering in suurstof verbruik het voortgegaan tydens eenlongnarkose. 2. Die aanvang van eenlongnarkose is geassosieerd met ’n verhoging in kardiale omset in vergelyking met albei die basislyn eenlongnarkose en wakker state. 3. Die gevolge van punte 1 en 2 hierbo is dat die gemengde veneuse suurstof saturasie vanaf 75% en die gemeng veneuse suurstof spanning vanaf 5.4 kPa (toe die pasiënte wakker was) gestyg het tydens4. Tydens eenlongnarkose het die betekenisvolle verhoging in veneuse oksigenasie veroorsaak dat daar ’n verhoging in arteriële oksigenasie was in vergelyking met wanneer die pasiënte wakker was. Hierdie styging in arteriele oksigenasie was ten spyte van die 37% aftakking wat teenwoordig was tydens eenlongnarkose. 5. Onder toestande in die huidige studie, het dobutamien tydens eenlongnarkose nog arteriële nog veneuse oksigenasie verbeter nie, maar die arteriele oksigenasie het konstant gebly. ’n Belangrike observasie wat daarmee saamgaan is dat dobutamien toediening nie met ’n daling in arteriële suurstof spanning geassosieer is nie. Vervolgens, die hipotese dat die verhoging in kardiale omset geassosieer met dobutamien toediening tydens eenlongnarkose ’n verhoging in arteriële oksigenasie beweeg bring, is dus verwerp. Die verwerping van die hipotese van die deel van die studie beteken dat die bevindinge die teenoorgestelde is van die studies gepubliseer deur Mathru en sy kollegas en Nomoto en Kawamura. Hierdie outeurs het gedemonstreer dat die toediening van inotrope ’n verhoging in arteriële oksigenasie teweeg gebring het. Nietemin is die teenoorgestelde gevolgtrekkinge nie teenstrydig met mekaar nie. Inteendeel hierdie verskille help ons om die effek van ’n verhoging in kardiale omset of arteriële oksigenasie in die teenwoordigheid van ’n betekenisvolle aftakking duidelik te maak. Die verskille tussen die studies kan op die volgende manier verduidelik word. Toestande wat in die huidige studie teenwoordig was het veroorsaak dat die verband tussen suurstof lewering en verbruik baie hoog was en dat die gemeng veneuse suurstof spanning baie hoog was om mee te begin alvorens dobutamien geinfuseer is. Dus is die veneuse saturasies op die plat deel van albei die suurstof dissosiasie kurwe en ook van die verband tussen kardiale omset en arteriële suurstof inhoud oorspronklik deur Kelman, Nunn en kollegas beskryf. Verdere verhogings in kardiale omset sou dus nie verwag word, en het nie, verhogings in gemeng veneuse suurstof spanning, gemeng veneuse suurstof saturasie of gemeng veneuse suurstof inhoud teweeg gebring. Dus, arteriële suurstof inhoud en saturasie het nie verander na die verhoging in kardiale omset wat teweeg gebring is deur die toediening van dobutamien in die huidige studie. Inteendeel, in die studie deur Mathru en kollegas, is die lae aanvanklike veneuse saturasie en spanning verbeter deur verhogings in die verband tussen suurstoflewering en suurstofverbruik. Omdat die veneuse saturasie aan die begin van die Mathru studie laag was, is betekenisvolle voordeel in arterieël oksigenasie teweeg gebring deur om die kardiale omset te verhoog. ’n Groot bekommernis vir die klinikus is dat die aftakking mag verhoog met die toediening van die inotroop dobutamien tydens eenlongnarkose en, op die manier, arteriële oksigenasie mag verminder. Die invloed van dobutamien op arteriële oksigenasie tydens eenlongnarkose mag teoreties te wyte wees aan die balans van die volgende uiteenlopende faktore: 1. Deur om die verband tussen suurstof lewering en verbruik te verbeter, sal dobutamien gemeng veneuse suurstof spanning verhoog. Hierdie verhoging sal arteriële oksigenasie verbeter in die teenwoordigheid van ’n groot aftakking, 2. Die bogenoemde moet teenoor potensiële verhogings in suurstofverbruik deur dobutamien oorweeg word. Die gevolge hiervan sou potensieel ’n vermindering in gemeng veneuse suurstof spanning wees. Sulke verhogings in suurstof verbruik is nie tydens die huidige studie gesien nie,3. ’n Verhoging in pulmonale arterie druk wat saamgaan met die verhoogde kardiale omset sal hipoksiese pulmonale vasokonstriksie teenwerk wat die aftakking in albei die geventileerde en nie geventileerde longe sal verhoog, 4. Direkte inhibisie van hipoksiese pulmonale vasokonstriksie deur dobutamien en, 5. Die invloed van gemeng veneuse suurstof spanning op hipoksiese pulmonale vasokonstriksie moet ook oorweeg word (d.i. hoe gemeng veneuse suurstof parsiele druk sal hipoksiese pulmonale vasokonstriksie inhibeer). Nietemin, ten spyte van die bekommernisse rondom hipoksemie tydens die toediening van dobutamien tydens eenlongnarkose, het dobutamien toediening nie ’n verlaging in arteriële suurstof spanning teweeg gebring nie, en ook het dit nie die koste van oksigenasie verhoog nie. Verder, die bevindinge van studies tydens eenlongnarkose in die laterale decubitus posisie deur Mathru en sy kollegas, Nomota en Kawamura en ook die huidige studie, dui aan dat die toediening van lae dosisse van dobutamien nie toe ’n verhoging in aftakking lei nie. Inteendeel, die voordelige effekte van die verhoging in kardiale omset op veneuse saturasie het veroorsaak dat daar ’n verhoging in arteriële saturasie is in die studie deur Mathru en sy kollegas soortgelyke meganismes is waarskynlik ook van toepassing in die studie wat gedoen is deur Nomoto en Kawamura. Dus, dwars deur die literatuur, is daar geen huidiglike bewys dat die toediening van dobutamien tot en met dosisse van 7μg.kg-1.min-1 aftakking verhoog of arteriële oksigenasie versleg in mense onderworpe aan eenlongnarkose in die laterale decubitus posisie. Dit is duidelik dat die vasodilatoriese effekte van dobutamien wat moontlik ’n verhoging in aftakking fraksie teweeg kan bring, nie die enigste faktore is om te oorweeg wanneer die middel se invloed op arteriële oksigenasie bestudeer word nie. Dit is ook van kliniese belang om die invloed van inotrope middels op veneuse suurstof inhoud te oorweeg. Dit is moontlik dat ’n aftakking verhoog kan word deur die toediening van ’n inotroop. Nietemin, mag die negatiewe effek wat die toediening van ’n inotroop sal inhou op arteriële oksigenasie deur middel van sy verhoging in aftakking, negeer word indien veneuse oksigenasie voordelig beïnvloed is. Verder, indien die verhoging in veneuse oksigenasie wat teweeggebring word deur die toediening van inotrope baie betekenisvol is, mag die gevolg hiervan wees dat arteriële oksigenasie voordelig beïnvloed word soos die geval in die huidige studie was. Die huidige benadering waar die kwaliteit van die bloed wat deur die aftakking vloei die arteriële oksigenasie beïnvloed, skuif die klem van voorkoming en behandeling van hipoksemie tydens eenlongnarkose van die long na die toereikendheid van die sirkulasie. Met ander woorde, die klem is geskuif van wat gebeur in die nie-geventileerde long (hipoksie pulmonale vasokonstriksie) tot primêr die toereikendheid van suurstof flux tydens eenlongnarkose. Ekstrinsieke en intrinsieke PEEP tydens eenlongnarkose Die invloed van PEEP op hemodinamika en oksigenasie tydens eenlongnarkose in die huidige studie mag as volg opgesom word. Toe PEEP5 tydens eenlongnarkose toegedien is: 1. Nie regter ventrikulêre funksie, hemodinamika, suurstof flux nog arteriële oksigenasie is beïnvloed deur die toediening van PEEP5 in vergelyking met die stap wanneer geen eksterne PEEP toegedien is nie. 2. Betekenisvolle hoeveelhede intrinsieke PEEP is teenwoordig tydens eenlongnarkose in die kontrole groep.Die hoeveelheid intrinsieke PEEP wat teenwoordig was, is swak maar betekenisvol verwant aan die graad obstruktiewe lugwegsiekte wat teenwoordig was gemeet deur pre-operatiewe longfunksie toetse. 3. Die waarskynlikste rede hoekom PEEP5 nie ’n verskil gemaak het aan oksigenasie of hemodinamika nie is die teenwoordigheid van soortgelyke hoeveelhede intrinsieke PEEP tydens eenlongnarkose. Hierdie bevinding bevestig Myle’s se beweringe dat lae vlakke intrinsieke PEEP voordelige effekte op oksigenasie tydens eenlongnarkose mag hê. PEEP10 toediening aan die onderlong tydens eenlongnarkose in die huidige studie het tot ’n vermindering in slagvolume gelei. Hierdie vermindering is primêr veroorsaak deur ’n vermindering in voorlading en nie die gevolg van ’n verhoging in pulmonale vaskulêre weerstand nie. Die gevolgtrekking is gemaak omdat regerventrikulere enddiastoliese volume verlaag het maar pulmonale vaskulêre weerstand het nie verhoog tot vlakke wat bekend is om regter ventrikulêre funksie te belemmer nie. Die vermindering in die verhouding tussen suurstof lewering en suurstof verbruik wat geïnduseer is deur PEEP10 het (voorspelbaar) gemeng veneuse suurstof spanning verminder en kon potensieël gelei het tot belemmering in arteriële oksigenasie. Indien minder voordelige sirkulatoriese toestande geheers het tydens die huidige studie, sou groter (oorbodige) hoeveelhede PEEP slegter kardiorespiratoriese gevolge tot gevolg gehad het. Ter opsomming, optimalisering van die volume van die onderlong tydens eenlongnarkose speel ’n belangrike rol in die bepaling van arteriële oksigenasie. Nietemin, die terapeutiese indeks vir PEEP is nou en die narkotiseur het die behoefte om te weet wanneer die volume van die onderlong optimaal is. In die opsig, is ’n betekenisvolle probleem tydens eenlongnarkose dat meting van funksionele residuele kapasiteit nie huidiglik maklik is nie
Boët, Angèle. "Fonction ventriculaire gauche et pathologies du cœur droit : Intérêt de la cardiométrie électrique". Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS301.
Testo completoRight heart overload is become since few years a real public health problem in congenital heart disease. Grow up with congenital heart disease patients have become a large population and suffer from many specific complications, like left ventricular failure. Right heart overload come mainly from two ways, volume or pressure that we reproduce thanks to two porcine models: tetralogy of Fallot (TOF) for volume and pulmonary hypertension (HYPPE). We try to determine on these models if there is early left heart failure and if electrical cardiometry can detect it.First part of this work is a validation of electrical cardiometry as cardiac output evaluation and fluid management reliable tool in healthy newborns and congenital heart disease patients.Second part is a left ventricle analysis of these models: we highlighted early left ventricle lesions of fibrosis, t-tubules disorganization, excitation-contraction coupling abnormalities associated with alteration of sarcomere relaxation and contraction. Even if first results are promising on large animals, we need to include more subjects to confirm these data.In conclusion, we highlighted than electrical cardiometry had an excellent and strong correlation with conductance catheter to evaluate LV contractility by noninvasive way. These results confirm this device usefulness in diagnosis and screening of our patients
Zhou, Yirong. "Left Ventricular Dynamics and Pulsatile Hemodynamics during Resuscitation of the Fibrillating Heart Using Direct Mechanical Ventricular Actuation". Wright State University / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=wright1547503362869157.
Testo completoCameli, Matteo. "Mechanical and histological disturbances in advanced heart failure and cardiac transplantation". Doctoral thesis, Umeå universitet, Kardiologi, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-127295.
Testo completoKoh, Carline, e 許上冕. "Effects of right ventricular pacing and its interruption on left ventricular torsional mechanics and diastolic function in congenitalheart block". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45167199.
Testo completoJörgensen, Kirsten. "Lung emphysema and cardiac function /". Göteborg : Dept. of Anaesthesiology and Intensive Care Medicine. Institute of Clinical Sciences, The Sahlgrenska Academy at Göteborg University, 2008. http://hdl.handle.net/2077/9635.
Testo completoCampbell, Stuart Gaylon. "The role of regulatory light chain phosphorylation in left ventricular function". Diss., [La Jolla] : University of California, San Diego, 2010. http://wwwlib.umi.com/cr/ucsd/fullcit?p3398511.
Testo completoTitle from first page of PDF file (viewed May 5, 2010). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references.
Nelson, Charles A. L. "Relationship between the transmural distribution of myocardial scar and ventricular function /". [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18564.pdf.
Testo completoShahgaldi, Kambiz. "Assessment of Left Ventricular Function and Hemodynamics Using Three-dimensional Echocardiography". Doctoral thesis, KTH, Medicinsk teknik, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-12966.
Testo completodegree of Medical DoctorQC 20100629
Ericsson, Anders B. "Cardioplegia and cardiac function : evaluated by left ventricular pressure-volume relations /". Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4138-6/.
Testo completoHart, Emma C. J. "The physiological mechanisms underpinning post-exercise reductions in left ventricular function". Thesis, Brunel University, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.443319.
Testo completoBrookes, Carl I. O. "The evaluation and assessment of right ventricular function using conductance catheters". Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326042.
Testo completoPatey, Olga. "Perinatal changes in fetal cardiac geometry, myocardial performance and ventricular function". Thesis, St George's, University of London, 2017. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.754075.
Testo completoPatel, Neil. "The assessment of right ventricular function in infants with pulmonary hypertension". Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/29312.
Testo completoArmour, Sylvia. "The Effects of the Transcription Factor SRY1 on Left Ventricular Function". University of Akron / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=akron1208193131.
Testo completoVisser, Lance Charles. "Echocardiographic Assessment of Right Ventricular Systolic Function in Conscious Healthy Dogs". The Ohio State University, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=osu1397419619.
Testo completoNishijima, Yoshinori. "Effects of single-site and multi-site ventricular pacing on left and right ventricular mechanics and synchrony is there an optimal pacing sequence? /". Connect to resource, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1126717344.
Testo completoHedberg, Pär. "Left ventricular systolic dysfunction in 75-year-old men and women : a community-based study of prevalence, screening and mitral annulus motion for diagnosis and prognostics /". Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5793.
Testo completoHuang, Hsin-Chi. "Cardiovascular magnetic resonance and right ventricular angiography in assessment of right ventricular volumes, function and wall motion abnormalities in arrhythmogenic right ventricular cardiomyopathy: a comparative study". Master's thesis, Faculty of Health Sciences, 2019. https://hdl.handle.net/11427/31643.
Testo completoFragata, Claudia da Silva. "Função atrial na miocardiopatia chagásica crônica". Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-20052013-113004/.
Testo completoBACKGROUND: Chagas disease (CD) pathogenesis is not fully known. Unlike the systolic and diastolic function of the left ventricle, the left atrial function still lacks information. OBJECTIVES: The aim of this study was to observe differences in patients with CD regarding the parameters of left atrial function and correlate them with Doppler echocardiographic parameters CASUISTIC AND METHODS: 85 subjects: 10 controls (GC), 26 in the indeterminate form (GI), 30 with ECG changes and normal left systolic function (GII) and 19 with left ventricular dysfunction (GIII) underwent echocardiography to assess left atrial and ventricular systolic and diastolic functions RESULTS: Reservoir function (TEF: total emptying fraction): there was a difference between groups (p <0.0001), lower mean in GIII compared to CG (p = 0.003), GI (p <0.001) and GII (p <0.001) with no difference between GC, GI and GII. Pulmonary veins flow: the S wave was no difference between groups (p = 0.003), lower mean in GIII compared to the CG (p = 0.01). Conduit function (PEF: passive emptying fraction): there was a difference between groups (p = 0.004), lower mean in GIII, without statistical significance between groups (GIII and GC, p = 0.06, GI and GII, p = 0.06, and GII and GIII, p = 0.07). Pump function (AEF: active emptying fraction): there was a difference between groups (p = 0.0001), lower mean in GIII compared to CG (p = 0.05), GI (p <0.0001) and GII (p = 0.002). Correlations: E/e\'mean and TEF: weak negative correlation (r = - 0.263, p = 0.02), moderate negative correlation in GIII (r = - 0.58, p = 0.02). E/e\'mean and PEF: no correlation (r = - 0.09, p = 0.44). E/e\'mean and AEF: moderate negative correlation (r = -0.36, p = 0.002) and GIII (r = - 0.57, p = 0.04). e\'mean and TEF: moderate positive correlation (r = 0.53, p <0.0001). e\'mean and PEF: moderate positive correlation (r = 0.49, p <0.0001). e\'mean and AEF: moderate positive correlation (r = 0.39, p = 0.001). LV ejection fraction and TEF: moderate positive correlation (r = 0.35, p = 0.003) and GIII (r = 0.52, p = 0.04). LV ejection fraction and PEF: moderate positive correlation (r = 0.42, p <0.0001). LV ejection fraction and AEF: moderate positive correlation (r = 0.35, p = 0.003). CONCLUSIONS: In patients with Chagas\' cardiomyopathy with left ventricular systolic dysfunction, there was impairment of the functions of reservoirs, conduit and pump of the left atrium
Carlsson, Camilla. "Development of a thin, soft, single segment conductance catheter for monitoring left ventricular pressure and volume". Licentiate thesis, KTH, Physics, 2002. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-1441.
Testo completoKnowledge of the leftventricular (LV) pressure-volume relation, along withparameters derived from this relation, have led to newpossibilities for the characterisation of cardiac pumpfunction, in both experimental studies and clinicalsettings.
The pressure-volume diagram is apowerful tool for visualising LV performance, but in order tobe clinically useful it is necessary to make plots continuouslyand on-line. The conductance catheter technique offers thispossibility. The conductance catheter system has experiencedgrowing interest among cardiologists, physiologists, surgeons,and anaesthesiologists around the world as a powerful newresearch tool, but the invasiveness of this technique has beena limiting factor for most clinical applications. The catheterneeds to be thinner and softer in order to make this techniquemore suitable for human use.
This thesis reports of a newthin and soft conductance catheter for continuously and on-linemeasurements of LV pressure and volume.
One way to reduce both cathetersize and stiffness is to decrease the number of electrodes onthe catheter. Theoretical calculations shown in this thesisproves that it is possible to obtain the same performance witha single segment catheter as with a five-segment catheter. Thethin catheter has been tested and compared to a commercialfive-segment conductance catheter in animal studies.
We conclude that the thin singlesegment conductance catheter can measure left ventricularvolume and pessure. The regression coefficient between the twomethods is good independent of loading condition and duringbaseline conditions the catheters produce very similar volumecurves. During preload reduction the estimated volume reductionis different in the two systems.
Our thin catheter does notdisturb the heart's normal electrophysiology, neither by thecatheter current nor by any mechanical stimuli. The resultsdemonstrates that our thin, soft, single segment conductancecatheter has performance characteristics which warrant furtherdevelopment, with the goal to make the method available forhuman use.
Vasconcelos, Milena Miranda. "Evolução da hipertrofia miocárdica associada à gestação em mulheres hipertensas após seis meses do parto". Botucatu, 2019. http://hdl.handle.net/11449/182458.
Testo completoResumo: Fundamento: A hipertensão arterial sistêmica (HAS) é um dos principais fatores de risco para o desenvolvimento de doença cardiovascular. Quando a mulher hipertensa engravida, ocorre uma nova condição hemodinâmica, com adição da situação de sobrecarga crônica de pressão à situação de sobrecarga crônica de volume. Essa nova condição hemodinâmica pode propiciar maior hipertrofia miocárdica (HVE), sendo que sua evolução após o parto ainda é pouco estudada na literatura. Suspeita-se que as mulheres hipertensas que apresentaram HVE durante gestação mantenham essa alteração cardíaca após o parto. Objetivos: Avaliar a hipertrofia miocárdica em mulheres hipertensas no terceiro trimestre da gestação e após seis meses do parto e estabelecer quais variáveis clínicas estão associadas com risco aumentado de hipertrofia miocárdica. Métodos: Estudo prospectivo longitudinal incluindo 41 mulheres gestantes com idade gestacional acima de 35 semanas e com diagnóstico prévio de HAS, acompanhadas no Ambulatório de Pré-Natal de Hipertensão Arterial do Serviço de Obstetrícia do Hospital das Clínicas da Faculdade de Medicina de Botucatu - UNESP. Foram submetidas às avaliações clínica e ecocardiográfica em dois momentos, período gestacional e período de seis meses após o parto. A HVE foi definida para índice de massa do ventrículo esquerdo indexada pela altura (IMVE) ≥ 45g/m2,7. Análise estatística: regressão logística multivariada com as exposições mais fortemente associadas com a manutenção da HVE n... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Background: Systemic arterial hypertension (SAH) is one of the principal risk factors for developing cardiovascular disease. When a hypertensive woman becomes pregnant, a new hemodynamic condition is installed, with addition from chronic pressure overload to chronic volume overload. This new hemodynamic condition can provides greater myocardial hypertrophy (LVH), whose postpartum evolution has been little studied in the literature. It is suspected that hypertensive women who presented LVH during pregnancy maintain this cardiac alteration after delivery. Objectives: To evaluate myocardial hypertrophy in hypertensive women in the third trimester of pregnancy and six months after delivery and to establish which clinical variables are associated with elevated risk of myocardial hypertrophy. Methods: Prospective longitudinal study including 41 pregnant women beyond 35 gestational weeks and with previous SAH diagnosis, monitored at the Hypertension Clinic of the Obstetrics Unit of the Botucatu School of Medicine - UNESP. They were submitted to clinical and echocardiographic evaluation at two moments, the gestational period and six months postpartum. LVH was defined for the left ventricular mass index as (LVMI) ≥ 45g/m2.7. Statistical analysis: multivariate logistic regression with the exposures most strongly associated with maintenance of hypertrophy in univariate analysis. Significance level: p<0.05. Results: The mean age was 29±6.2 years; mean gestacional age was 36.7±1.18 weeks;... (Complete abstract click electronic access below)
Mestre
Gustafsson, Ulf. "Ventricular rotation and the rotation axis : a new concept in cardiac function". Doctoral thesis, Umeå universitet, Medicin, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-37187.
Testo completoBorges, Maria Candida Calzada. "Redução da função sistolica e diastolica do ventriculo esquerdo, estimada pela velocidade do anel mitral, em pacientes hipertensos com e sem hipertrofia ventricular". [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310233.
Testo completoTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-07T12:07:47Z (GMT). No. of bitstreams: 1 Borges_MariaCandidaCalzada_D.pdf: 3690302 bytes, checksum: 0c73a392de92a2836881cbe3034c49f5 (MD5) Previous issue date: 2006
Resumo: Estudos epidemiológicos têm estabelecido uma relação contínua entre a massa do ventrículo esquerdo (VE) e o risco cardiovascular na população geral e na população hipertensa. O pior prognóstico de pacientes hipertensos com aumento na massa do VE tem sido, em parte, atribuído à disfunção do miocárdio, mas permanece desconhecido se os pacientes hipertensos sem hipertrofia do VE (HVE) definida pelos critérios habituais apresentam alterações na função do miocárdio. Os índices ecocardiográficos derivados das dimensões do VE e das velocidades do fluxo mitral aferidas através do Doppler têm provado ser geralmente não específicos e insensíveis para a detecção de alterações discretas da dinâmica ventricular. O Doppler Tecidual (DT) tem demonstrado ser um método eficiente e rápido para avaliar a função do miocárdio. Nos pacientes hipertensos com hipertrofia do VE tem sido descrita redução das velocidades sistólica e diastólica inicial. Entretanto não tem sido relatada investigação da função sistólica do miocárdio do VE através do DT em pacientes hipertensos sem ou com discreta elevação da massa do VE. O presente estudo avalia se, através da velocidade sistólica e diastólica aferidas pelo DT, é possível identificar alterações na contração e relaxamento do miocárdio de indivíduos hipertensos com ou sem hipertrofia ventricular definida pelos valores de corte habituais e com fração de ejeção preservada. Para tanto indivíduos normotensos e hipertensos com ou sem hipertrofia do ventrículo esquerdo (índice de massa do VE [IMVE] > 51g/m2.7) foram avaliados através da ecocardiografia convencional e do DT em 5 segmentos do anel mitral. Os subgrupos incluíram indivíduos normotensos não obesos (n=16; idade 51 ± 9 anos; 11 feminino; pressão arterial sistólica [PAS] 109 ± 11 mmHg; índice de massa corpórea [IMC] 24 ± 2,7 Kg/m2 ; IMVE 32 ± 5.5g/m2.7), hipertensos não obesos sem HVE (n=16; idade 54 ± 12 anos ; 12 femininos; PAS 166 ± 15 mmHg; IMC 25 ± 2,7 g/m2; IMVE 42 ± 5,5 g/m2.7) e hipertensos não obesos com HVE (n=22; idade 56 ± 10 anos; 10 feminino; PAS 181 ± 19 mmHg; IMC 26 ± 2,3 g/m2; IMVE 69 ± 16 g/m2.7). A fração de ejeção foi comparável entre os subgrupos, mas a fração de encurtamento da parede média foi reduzida nos pacientes hipertensos com hipertrofia do VE (¿26%). O tempo de relaxamento isovolumétrico foi aumentado nos pacientes hipertensos com hipertrofia do VE, enquanto a velocidade A do fluxo mitral encontrou-se aumentada em indivíduos hipertensos com e sem hipertrofia do VE. A velocidade sistólica (SM) e diastólica inicial (EM) aferida através do DT ao nível do anel mitral encontraram-se significativamente reduzidas nos indivíduos hipertensos com e sem HVE quando comparadas com as dos indivíduos normotensos. Evidenciou-se correlação positiva entre SM e EM (r=0,68; p<0,0001) e correlação negativa entre essas duas variáveis e o IMVE (SM, r= -0,41; p=0,002; EM, r= -0,56; p<0,0001). Portanto a redução na velocidade sistólica e diastólica ao nível do anel mitral acompanha o aumento da massa do VE em indivíduos hipertensos, iniciando-se em níveis de IMVE que se encontram abaixo dos valores definidos clinicamente como normais
Abstract: Epidemiological studies have established a continuous relationship between the left ventricular (LV) mass and cardiovascular risk in the general and hypertensive population. The poorer prognosis of hypertensive subjects with major increases in LV mass has been, in part, attributed to myocardial dysfunction, but it remains unknown whether hypertensive subjects without clinically defined LV hypertrophy have subtle abnormalities of myocardial function. Echocardiographic indices derived from LV chamber dimensions and Doppler measurements of flow velocities have been proved to be generally nonspecific and insensitive for the detection of minor abnormalities of cardiac relaxation and contraction. Tissue Doppler imaging (TDI) has been advocated as a reliable, rapid, and efficient method to assess myocardial function. In hypertensive patients with LV hypertrophy, TDI mitral annulus systolic and diastolic velocities have been shown to be reduced. However, a comprehensive TDI approach has not been reported in hypertensive subjects without or with minor increases in LV mass. The present study examines whether, by using TDI early systolic and diastolic velocities, one might identify changes in LV myocardial contraction and relaxation in subsets of hypertensive with and without clear-cut, clinically defined LV hypertrophy and normal LV ejection fraction. Normotensive and hypertensive subjects with and without left ventricular (LV) hypertrophy (LV mass index [LVMI] =51 g/m2.7) were examined by conventional echocardiography and tissue Doppler imaging of mitral annulus motion. The subgroups included non obese normotensive subjects (n=16; age 51±9 years; 11 female; systolic blood pressure [SBP] 109±11 mm Hg, body mass index [BMI] 24±2.7 kg/m2; LVMI 32±5.5 g/m2.7), non obese hypertensive subjects without LV hypertrophy (n=16; age 54±12 years; 12 female; SBP 166±15 mm Hg; BMI 25±2.7 kg/m2; LVMI 42_5.5 g/m2.7), and hypertensive subjects with LV hypertrophy (n=22; age 56±10 years; 10 female; SBP 181±19 mm Hg; BMI 26±2.3 kg/m2; LVMI 69±16 g/m2.7). Ejection fraction was comparable among the subgroups, but midwall fractional shortening was reduced in hypertensive subjects with LV hypertrophy (¿26%). Isovolumic relaxation time was increased in subjects with LV hypertrophy, whereas mitral wave A velocity was increased in hypertensive subjects with and without LV hypertrophy. Tissue Doppler imaging mitral annulus systolic (SM) and diastolic (EM) velocities were reduced in subjects with and without LV hypertrophy compared with normotensive subjects. There was a positive correlation between SM and EM (r=0.68; P<0.0001) and negative correlations between these 2 variables and LVMI (SM, r= -0.41; P=0.002; EM, r=-0.56; P<0.0001). Thus, reductions in mitral annulus systolic and diastolic velocities parallel increases in LV mass in hypertensive subjects, beginning at LV mass within the clinically defined normal values
Doutorado
Medicina Experimental
Doutor em Fisiopatologia Medica
Man, Bik-ling. "Plasma brain natriuretic peptide and systemic ventricular function after the Fontan procedure /". View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B34865822.
Testo completoÄrnlöv, Johan. "Left Ventricular Function in Elderly Men : Metabolic, Hormonal, Genetic and Prognostic Implications". Doctoral thesis, Uppsala University, Department of Public Health and Caring Sciences, 2002. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2937.
Testo completoHeart failure and left ventricular dysfunction are major causes of morbidity and mortality. In this thesis, metabolic, hormonal, genetic and prognostic aspects of echocardiographically determined left ventricular function were investigated in a fairly large longitudinal population-based study of men. The participants were examined both at age 50 and 70 years and were followed for mortality using the national cause-of-death registry.
Several factors associated with the insulin resistance syndrome predicted left ventricular systolic dysfunction independent of myocardial infarction, hypertension, diabetes and the use of cardiovascular medication after twenty years follow-up. Plasma levels of N-terminal atrial natriuretic peptide (N-ANP) were significantly increased in men with left ventricular dysfunction in comparison to healthy men. However, the diagnostic accuracy was poor due to the extensive overlapping between the groups. Relations between a haplotype of the novel hUNC-93B1 gene and the E/A-ratio were found and validated in separate samples of the cohort. Myocardial performance index (a Doppler derived index of combined left ventricular systolic and diastolic function) and left ventricular ejection fraction were found to be predictors for cardiovascular mortality independent of traditional cardiovascular risk factors in a longitudinal analysis with a mean follow-up of seven years.
In conclusion, this thesis showed that left ventricular function is influenced by metabolic, hormonal and genetic factors and that echocardiographic measurements of left ventricular function, such as the myocardial performance index, are strong independent risk factors for cardiovascular mortality in elderly men.
Calcutteea, Avin. "New insights in the assessment of right ventricular function : an echocardiographic study". Doctoral thesis, Umeå universitet, Medicin, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-66725.
Testo completoMan, Bik-ling, e 文碧玲. "Plasma brain natriuretic peptide and systemic ventricular function after the Fontan procedure". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45010365.
Testo completoNeary, Paul. "Studies of sarcoplasmic reticulum function in rabbit and human left ventricular dysfunction". Thesis, University of Glasgow, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300737.
Testo completoCheesman, M. G. "Right ventricular function in paced patients : a study using pulsed Doppler ultrasound". Thesis, University of Leicester, 1991. http://hdl.handle.net/2381/34299.
Testo completoYoung, Lesley Elissa. "Measurement of left ventricular function in anaesthetised horses using transoesophageal Doppler echocardiography". Thesis, University of Edinburgh, 1996. http://hdl.handle.net/1842/30053.
Testo completoBilal, Dejan. "Evaluation of systolic and diastolic left ventricular function during exercise in athletes". Thesis, Malmö universitet, Fakulteten för hälsa och samhälle (HS), 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-25669.
Testo completoAthlete’s heart is a cardiovascular condition that occurs during extended periods of intense exercise that causes structural, functional and electrical changes of the heart and is a physiological adaptation in response to increased hemodynamic needs during physical exertion. However, the physiological adaptations have become a diagnostic dilemma to distinguish from the pathological changes such as hypertrophic cardiomyopathy. Therefore, there is a need for standardization of cardiovascular screening in athletes to detect underlying or hidden cardiomyopathies that can lead to severe consequences during physical exercise. The aim of the present study was to investigate the systolic and diastolic left ventricular function during exercise in athletes and to increase the understanding of what happens to the various variables during exertion. Nine healthy athletes conducted stress echocardiography where cardiac index, ejection fraction, filling pressure, mitral annular plane systolic excursion (MAPSE), mitral inflow, tissue Doppler imaging (e 'and s') and pulmonary venous inflow were examined before, during and after a cycle ergometer test. The variables during and after the cycle test were then compared to baseline. The results showed a significant increase in cardiac index, MAPSE, and tissue Doppler imaging during exertion. In conclusion, the study showed that several of the variables improved during exertion and some of them proved to be quite insensitive to disturbances and artifacts, which may be useful in future study protocols that consider carrying out a cardiac study during work.
Dawes, Timothy. "The anthropometric, environmental and genetic determinants of right ventricular structure and function". Thesis, Imperial College London, 2015. http://hdl.handle.net/10044/1/30634.
Testo completo